Drug Trial Radar · NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
284
Planned (sponsor's estimate)
Start
May 8, 2025
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- May 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Conditions
- Schizophrenia
Interventions
NBI-1117568Drug
NBI-1117568 will be administered per schedule specified in the arm description.
PlaceboDrug
Placebo will be administered per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 5Time frame: Baseline, Week 5
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Bryant, Arkansas · Recruiting
Neurocrine Clinical Site
Little Rock, Arkansas · Recruiting
Neurocrine Clinical Site
Anaheim, California · Recruiting
Neurocrine Clinical Site
Pico Rivera, California · Recruiting
Neurocrine Clinical Site
San Diego, California · Recruiting
Neurocrine Clinical Site
Sherman Oaks, California · Recruiting
Neurocrine Clinical Site
Torrance, California · Recruiting
Neurocrine Clinical Site
Hollywood, Florida · Recruiting
Neurocrine Clinical Site
Miami Lakes, Florida · Recruiting
Neurocrine Clinical Site
Atlanta, Georgia · Recruiting
Neurocrine Clinical Site
Decatur, Georgia · Recruiting
Neurocrine Clinical Site
Snellville, Georgia · Recruiting
Neurocrine Clinical Site
Chicago, Illinois · Recruiting
Neurocrine Clinical Site
Gaithersburg, Maryland · Recruiting
Neurocrine Clinical Site
Watertown, Massachusetts · Recruiting
Neurocrine Clinical Site
Marlton, New Jersey · Recruiting
Neurocrine Clinical Site
Staten Island, New York · Recruiting
Neurocrine Clinical Site
The Bronx, New York · Recruiting
Neurocrine Clinical Site
Austin, Texas · Recruiting
Neurocrine Clinical Site
DeSoto, Texas · Recruiting
Neurocrine Clinical Site
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.